publication date: Mar. 16, 2018

Conversation with the Cancer Letter Basch: Patient-reported outcomes data can make cancer drugs safer, more tolerable Ethan Basch

Ethan Basch

Director of the Cancer Outcomes Research Program, professor of medicine and public health at the UNC Lineberger Comprehensive Cancer Center.

 

Fifteen years ago, when Ethan Basch started developing measures for aggregating patient-reported outcomes, many of his colleagues in oncology saw no promise in this enterprise.

“We conducted cooperative group studies and showed that the vast majority of patients were willing and able to self-report even when extremely ill or close to death or hospice,” said Basch, director of the Cancer Outcomes Research Program and professor of medicine and public health at the UNC Lineberger Comprehensive Cancer Center.

“These data were useful for responding to my skeptical colleagues who asserted, ‘We understand our patients well, so we don’t need them to provide their own information. We know what’s going on with them, we talk to them all the time. And patients probably aren’t willing or able to report their toxicities during trials, they have a lot going on.’ But our data showed those assertions were not true.”

Now, NCI plans to commit $3.25 … Continue reading Basch: Patient-reported outcomes data can make cancer drugs safer, more tolerable

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.